Impax Laboratories Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Hayward CA United States (1993)
Status: Acquired by Amneal Pharmaceuticals (2017)

Organization Overview

First Clinical Trial
2005
NCT00239564
First Marketed Drug
1993
oxytetracycline (terramycin)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

IMPAX | Impax Laboratories (Impax Pharmaceuticals, a division of Impax Laboratories) | IMPAX Laboratories, Inc. | Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax) | Impax Laboratories, LLC | IMPAX LABS | IMPAX LABS INC | Impax Pharmaceuticals, a division of Impax Laboratories | Impax Pharmaceuticals, a division of Impx Laboratories. | Impax Pharmaceuticals Division (Impax) , a Division of Impax Laboratories Inc. | IMPAX PHARMS | RoundTable Healthcare Partners